Yes, most patients benefit from continuing metformin while adding tirzepatide
Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F
Pre-eclampsia also increases the risk of ASD (231), but the presence of organ dysfunction in pre-eclampsia does not appear to be an additional risk factor (23, 230)
Thus, although not specifically indicated, these findings support the rapid improvement of venous system function as an essential common point to prevent and reverse the noxious chain of events and attenuate all harmful consequences
The manufactures doses will only be produced by the manufacturer and may be in shortage, but compounded custom doses may continue even after the regulatory changes
Although not FDA approved for weight loss, Ozempic is associated with weight loss, and healthcare providers may prescribe it off-label for this use